Celcuity Inc.

CELC chart

Celcuity Inc. news

• FDA accepts Celcuity sNDA for gedatolisib in PIK3CA-mutant breast cancer

  StreetInsider · Nov 9, 10:35 AM EST

• FDA accepts Celcuity application for expanded breast cancer use

  Investing.com · Nov 9, 9:24 AM EST

• Celcuity Inc. (CELC) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Nov 9, 9:10 AM EST

• Celcuity Announces FDA Acceptance of sNDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer

  Yahoo Finance · Nov 9, 8:30 AM EST

• Celcuity Announces FDA Acceptance of sNDA for REVTORPYK™

  GlobeNewswire · Nov 9, 8:30 AM EST

• Citizens reaffirms Celcuity stock rating on competitive positioning

  Investing.com · Nov 9, 7:27 AM EST

• Is Celcuity (CELC) Undervalued After Its Q3 Loss Raised Fresh Questions?

  Simply Wall St · Nov 9, 7:21 AM EST

• HC Wainwright & Co. maintains Celcuity at Buy, lowers price target to $150 from $155

  TradingView · Nov 9, 6:41 AM EST

• Celcuity Stock Price Forecast. Should You Buy CELC?

  StockInvest.us · Nov 6, 5:21 PM EST

• How Investors Are Reacting To Celcuity (CELC) Wider Loss And Trial Data

  Simply Wall St · Nov 6, 1:29 PM EST

• Celcuity (CELC) Q3 2026 Earnings Call Transcript

  fool.com · Nov 6, 12:05 PM EST

• Celcuity Inc. (CELC) stock price, news, quote and history

  Yahoo Finance Singapore · Nov 6, 10:09 AM EST

Celcuity Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-05
• 8-K8-K2026-11-05
• 8-K8-K2026-10-02
• 8-K8-K2026-09-30
• 8-K8-K2026-08-26
• 10-Q10-Q2026-08-13
• 8-K8-K2026-08-13
• 8-K/A8-K/A2026-07-15
• 8-K8-K2026-07-15
• 8-K8-K2026-06-08
• 8-K8-K2026-06-02
• 8-K/A8-K/A2026-05-20

About Celcuity Inc.

Ticker

CELC (Nasdaq)

Industry

Services-Medical Laboratories

Headquarters

Minneapolis, MN

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1603454

Former names

Celcuity LLC

Frequently asked questions